SVB Leerink Downgrades Incyte (INCY) to Underperform
Tweet
Share
E-mailGet Alerts INCY Hot Sheet
Price: $85.09 +1.08%
Rating Summary:
18 Buy, 14 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 22 | Down: 11 | New: 74
Rating Summary:
18 Buy, 14 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 22 | Down: 11 | New: 74
Trade Now!
Join SI Premium – FREE
SVB Leerink analyst Andrew S. Berens downgraded Incyte (NASDAQ: INCY) from Market Perform to Underperform with a price target of $70.00.
For an analyst ratings summary and ratings history on Incyte click here. For more ratings news on Incyte click here.
Shares of Incyte closed at $89.00 yesterday.
You May Also Be Interested In
- Incyte (INCY) Announces New Findings from a Randomized Phase 2 Study of Ruxolitinib Cream in Patients with Vitiligo
- Lilly and Incyte's Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study
- Raymond James Downgrades Southwestern Energy (SWN) to Underperform
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
